Hunter Jessica Ezzell, Schneider Jennifer L, Firemark Alison J, Davis James V, Gille Sara, Pawloski Pamala A, Liang Su-Ying, Schlieder Victoria, Rahm Alanna Kulchak
Genomics, Ethics, and Translational Research Program, RTI International, Research Triangle Park, NC.
Kaiser Permanente Center for Health Research, Portland, OR.
J Patient Cent Res Rev. 2022 Oct 18;9(4):282-289. doi: 10.17294/2330-0698.1945. eCollection 2022 Fall.
Genetic information has health implications for patients and their biological relatives. Death of a patient before sharing a genetic diagnosis with at-risk relatives is a missed opportunity to provide important information that could guide interventions to minimize cancer-related morbidity and mortality in relatives.
We performed semi-structured interviews with individuals diagnosed with Lynch syndrome at 1 of 4 health systems to explore their perspectives on whether health systems should share genetic risk information with relatives following a patient's death. An inductive, open-coding approach was used to analyze audio-recorded content, with software-generated code reports undergoing iterative comparative analysis by a qualitative research team to identify broad themes and representative participant quotes.
Among 23 participating interviewees, 19 supported health systems informing relatives about their Lynch syndrome risk while the remaining 4 were conflicted about patient privacy. Most (n=22) wanted their Lynch syndrome diagnosis shared with relatives if they were unable to share and to be informed of their own risk if a diagnosed relative was unable to share. The most common issues noted regarding information-sharing with relatives included patient privacy and privacy laws (n=8), potential anxiety (n=5), and lack of contact information for relatives (n=3). Interviewee perspectives on how health systems could communicate genetic findings generated a consensus: When - a few months after but within a year of the patient's death; How - explanatory letter and follow-up phone call; and Who - a knowledgeable professional.
Interviews demonstrated strong and consistent perspectives from individuals diagnosed with Lynch syndrome that health systems have a role and responsibility to inform relatives of genetic findings following a patient's death.
基因信息对患者及其生物学亲属的健康具有重要意义。患者在与高危亲属分享基因诊断结果之前死亡,就错失了提供重要信息的机会,而这些信息可以指导采取干预措施,以尽量减少亲属患癌相关的发病率和死亡率。
我们对在4个医疗系统之一被诊断为林奇综合征的个体进行了半结构化访谈,以探讨他们对于医疗系统在患者死亡后是否应与亲属分享基因风险信息的看法。采用归纳式开放编码方法分析录音内容,定性研究团队对软件生成的代码报告进行迭代比较分析,以确定广泛的主题和有代表性的参与者引述。
在23名参与访谈的人中,19人支持医疗系统告知亲属其患林奇综合征的风险,其余4人在患者隐私问题上存在矛盾态度。大多数人(n = 22)希望如果自己无法分享,其林奇综合征诊断结果能告知亲属;如果已确诊的亲属无法分享,他们也希望了解自身风险。与亲属分享信息时最常提到的问题包括患者隐私和隐私法(n = 8)、潜在焦虑(n = 5)以及缺乏亲属的联系信息(n = 3)。关于医疗系统如何传达基因检测结果,受访者的观点达成了共识:何时——在患者死亡后的几个月内但不超过一年;如何——通过解释信和后续电话;以及由谁——一位知识渊博的专业人员。
访谈表明,被诊断为林奇综合征的个体有着强烈且一致的观点,即医疗系统有责任在患者死亡后告知亲属基因检测结果。